MW
IBRX icon

Maia Wealth’s ImmunityBio IBRX Stock Holding History

Maia Wealth’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$126K Hold
14,396
– – 0.02% 354
2026
Q1 		$110K Hold
14,396
– – 0.02% 341
2025
Q4 		$95.3K Hold
14,396
– – 0.02% 339
2025
Q3 		$31.1K Sell
14,396
-70
-0.5% -$180 0.01% 337
2025
Q2 		$38.2K Buy
14,466
+70
+0.5% +$188 0.01% 321
2025
Q1 		$41.6K Hold
14,396
– – 0.01% 290
2024
Q4 		$45.1K Buy
+14,396
New +$60K 0.01% 302

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Maia Wealth's IBRX Position: Q2 2026 in Review

Maia Wealth held its ImmunityBio (IBRX) position steady in Q2 2026 at 14,396 shares worth $126K. The position accounts for 0.02% of the portfolio, ranked #354.

Maia Wealth first reported a position in IBRX in Q4 2024 and has held it in 7 quarters since. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Maia Wealth held 14,396 shares of ImmunityBio worth $126K as of Q2 2026.
  • Maia Wealth left its ImmunityBio share count unchanged in Q2 2026.
  • ImmunityBio made up 0.02% of Maia Wealth's portfolio in Q2 2026, its #354 holding.
  • Maia Wealth first reported a position in ImmunityBio in Q4 2024 and has held it in 7 quarters since.
  • 404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Maia Wealth's 13F filing for Q2 2026, filed 28 Jul 2026.